Connection

NANDAN KUMAR MONDAL to Heart Failure

This is a "connection" page, showing publications NANDAN KUMAR MONDAL has written about Heart Failure.
Connection Strength

2.690
  1. Preoperative brain volume loss is associated with postoperative delirium in advanced heart failure patients supported by left ventricular assist device. Sci Rep. 2025 Mar 14; 15(1):8884.
    View in: PubMed
    Score: 0.377
  2. Machine Learning Assisted Stroke Prediction in Mechanical Circulatory Support: Predictive Role of Systemic Mitochondrial Dysfunction. ASAIO J. 2025 05 01; 71(5):387-394.
    View in: PubMed
    Score: 0.367
  3. Association of Oxidative Stress and Platelet Receptor Glycoprotein GPIba and GPVI Shedding During Nonsurgical Bleeding in Heart Failure Patients With Continuous-Flow Left Ventricular Assist Device Support. ASAIO J. 2018 Jul/Aug; 64(4):462-471.
    View in: PubMed
    Score: 0.237
  4. Oxidative stress induced modulation of platelet integrin a2b?3 expression and shedding may predict the risk of major bleeding in heart failure patients supported by continuous flow left ventricular assist devices. Thromb Res. 2017 Oct; 158:140-148.
    View in: PubMed
    Score: 0.224
  5. Mechanistic insight of platelet apoptosis leading to non-surgical bleeding among heart failure patients supported by continuous-flow left ventricular assist devices. Mol Cell Biochem. 2017 Sep; 433(1-2):125-137.
    View in: PubMed
    Score: 0.217
  6. Infection, Oxidative Stress, and Changes in Circulating Regulatory T Cells of Heart Failure Patients Supported by Continuous-Flow Ventricular Assist Devices. ASAIO J. 2017 Mar/Apr; 63(2):128-133.
    View in: PubMed
    Score: 0.216
  7. Systemic Inflammatory Response Syndrome in End-Stage Heart Failure Patients Following Continuous-Flow Left Ventricular Assist Device Implantation: Differences in Plasma Redox Status and Leukocyte Activation. Artif Organs. 2016 May; 40(5):434-43.
    View in: PubMed
    Score: 0.196
  8. Systemic Inflammatory Response Syndrome After Contentious-Flow Left Ventricular Assist Device Implantation and Change in Platelet Mitochondrial Membrane Potential. J Card Fail. 2015 Jul; 21(7):564-71.
    View in: PubMed
    Score: 0.190
  9. Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device. Platelets. 2015; 26(6):536-44.
    View in: PubMed
    Score: 0.181
  10. Oxidative stress, DNA damage and repair in heart failure patients after implantation of continuous flow left ventricular assist devices. Int J Med Sci. 2013; 10(7):883-93.
    View in: PubMed
    Score: 0.166
  11. Kidney Function Trajectories and Right Heart Failure Following LVAD Implantation. J Am Heart Assoc. 2024 Mar 05; 13(5):e031305.
    View in: PubMed
    Score: 0.088
  12. Distinctive kidney function trajectories following left ventricular assist device implantation. J Heart Lung Transplant. 2022 12; 41(12):1798-1807.
    View in: PubMed
    Score: 0.079
  13. Management of Antiplatelet Therapy During Continuous-Flow Left Ventricular Assist Device Support After Thrombotic Hemorrhagic Events. ASAIO J. 2019 Sep/Oct; 65(7):683-689.
    View in: PubMed
    Score: 0.064
  14. Comparison of intraplatelet reactive oxygen species, mitochondrial damage, and platelet apoptosis after implantation of three continuous flow left ventricular assist devices: HeartMate II, Jarvik 2000, and HeartWare. ASAIO J. 2015 May-Jun; 61(3):244-52.
    View in: PubMed
    Score: 0.048
  15. Platelet glycoprotein Iba ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2014 Jan; 33(1):71-9.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.